— Know what they know.
Not Investment Advice
Also trades as: 0Y6X.L (LSE) · $vol 1M · 2M6.DE (XETRA) · $vol 0M

MDT NYSE

Medtronic Plc
1W: -0.7% 1M: +5.0% 3M: +8.2% YTD: +0.3% 1Y: +3.6% 3Y: +42.6% 5Y: -9.8%
$93.95
-0.84 (-0.89%)
 
Weekly Expected Move ±4.3%
$87 $91 $95 $99 $104
NYSE · Healthcare · Medical - Devices · Tech Score Buy · Power 80 · $120.2B mcap · 1.28B float · 1.11% daily turnover · Short 48% of daily vol
Credit Risk of going bust: lower than 81% of companies Debt: 19.0% of company value Bonds: $175.5M held by 166 funds, 54 bp over Treasuries → details ▾
If the stock fell to about $1.30 (down 99%), Medtronic Plc would be worth roughly what it owes.
Total debt $28.15B against a stock market value of $120.18B.
Distance to default 10.00 (Merton model): prices to 2026-10-27, balance sheet 2026-07-31, debt counted $15.34B (short-term plus half of long-term), stock volatility 24.6%; Altman Z'' 3.81. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Supply Chain Overview

11 relationships
8
As Filer
counterparties named
3
As Counterparty
mentioned by others
1
Rel. Types
2022-09-21
Earliest Filing
2026-03-09
Latest Filing
partner: 8

Counterparties (Filed by MDT)

8 relationships

Companies named in MDT's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Medtronic plc MDT partner Parent company issuing senior notes via subsidiary 2022-09-21 View
Medtronic Global Holdings S.C.A. MDT partner Subsidiary issuing senior notes 2022-09-21 View
Medtronic, Inc. MDT partner Indirect subsidiary guaranteeing the notes 2022-09-21 View
Computershare Trust Company, N.A. — partner Trustee for the indenture 2022-09-21 View
Elavon Financial Services DAC — partner Paying agent for the notes 2022-09-21 View
Barclays Bank PLC TAPR partner Representative of underwriters 2022-09-21 View
Citigroup Global Markets Limited — partner Representative of underwriters 2022-09-21 View
HSBC Continental Europe — partner Representative of underwriters 2022-09-21 View

Mentioned As Counterparty

3 mentions

Other companies that named MDT in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
MMED MiniMed Group, Inc. partner Parent company prior to IPO; transferred Diabetes business assets to MiniMed; retains ~90% ownership post-IPO. 2026-03-09 View
AVR Anteris Technologies Global Corp. investor Parent company of the PIPE investor 2026-01-22 View
OBIO Orchestra BioMed Holdings, Inc. investor Parent company of affiliate Covidien Group S.à.r.l., a PIPE investor 2025-08-04 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-10-19 Officer/Director Change; Shareholder Vote; Regulation FD; Exhibits View
2026-09-17 Other Events; Exhibits View
2026-09-01 Earnings Release; Exhibits View
2026-06-03 Earnings Release; Exhibits View
2026-05-18 Officer/Director Change; Exhibits View
2026-04-27 Regulation FD; Exhibits View
2026-03-24 Regulation FD View
2026-02-17 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-11-18 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-11-03 Departure/Election of Directors; Appointment of Officers View
2025-10-21 Amendments to Articles of Incorporation or Bylaws; Submission of Matters to a Vote of Security Holde View
2025-09-29 Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits Agreement View
2025-09-16 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-08-19 Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic View
2025-06-23 Departure/Election of Directors; Appointment of Officers View
2025-05-21 Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic View
2025-03-17 Departure/Election of Directors; Appointment of Officers View
2025-02-18 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-01-21 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2024-11-19 Results of Operations and Financial Condition; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms